ANGELA LIBRANTI: Open Payments
NPI 1497240675 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 50 payments from 12 companies in 2025. Trend: 2023 $860 · 2024 $1,362 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $443 |
| GENZYME CORPORATION | 5 | $152 |
| Janssen Biotech, Inc. | 10 | $146 |
| Amgen Inc. | 3 | $76 |
| LEO Pharma Inc. | 3 | $74 |
| Incyte Corporation | 3 | $66 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $35 |
| Botanix SB Inc | 1 | $33 |
| SpringWorks Therapeutics, Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $22 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, OTEZLA, OPZELURA, ANZUPGO, Winlevi, SOFDRA.
Industry payments across NY — which companies pay providers there.
